William Cao, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 18 Sisson Rd, Harwich Port, MA 02646 Phone: 508-432-0895 Fax: 508-432-3508 |
Dr. Elizabeth Grace Allen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Main St, 6 Post Office Sq, Harwich Port, MA 02646 Phone: 508-430-0660 |
Luke James Moseley, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 18 Sisson Rd, Harwich Port, MA 02646 Phone: 508-432-0895 |
Si Cheng Lei Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6 Post Office Sq, Harwich Port, MA 02646 Phone: 508-430-0660 |
News Archive
Adolescent cannabis use has been linked to an increased risk of depression and suicidal behavior in young adulthood, according to the first meta-analysis by a team of scientists at the Research Institute of the McGill University Health Centre and McGill University, in collaboration with the University of Oxford and Rutgers University-Camden, which is published in the journal JAMA Psychiatry today.
To date, a cure for Parkinson's disease remains elusive for the more than 50,000 Americans diagnosed yearly, despite decades of intensive study. But a newly approved treatment that might help ease the symptoms of Parkinson's has shown remarkable promise.
People with a stable psychosocial life situation often delay in seeking help for their alcohol problems - even though they are serious.
Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today that it has partnered with Terumo Corporation to be the exclusive distributor of the GLIDEWIRE Urologic Hydrophilic Coated Guidewire, a device cleared by the FDA for urological use.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that its SGX301 (synthetic hypericin) development program for the first-line treatment of cutaneous T-cell lymphoma (CTCL) has received "Fast Track" designation from the US Food and Drug Administration.
› Verified 7 days ago